Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea

Arturo Cortés-Telles, Stephanie López-Romero, Esperanza Figueroa-Hurtado, Yuri Noemi Pou-Aguilar, Alyson W Wong, Kathryn M Milne, Christopher J Ryerson, Jordan A Guenette, Arturo Cortés-Telles, Stephanie López-Romero, Esperanza Figueroa-Hurtado, Yuri Noemi Pou-Aguilar, Alyson W Wong, Kathryn M Milne, Christopher J Ryerson, Jordan A Guenette

Abstract

The purpose of this study was to examine the physiological mechanisms of persistent dyspnoea in COVID-19 survivors. Non-critical patients (n = 186) with varying degrees of COVID-19 severity reported persistent symptoms using a standardized questionnaire and underwent pulmonary function and 6-minute walk testing between 30 and 90 days following the onset of acute COVID-19 symptoms. Patients were divided into those with (n = 70) and without (n = 116) persistent dyspnoea. Patients with persistent dyspnoea had significantly lower FVC (p = 0.03), FEV1 (p = 0.04), DLCO (p = 0.01), 6-minute walk distance (% predicted, p = 0.03), and end-exercise oxygen saturation (p < 0.001), and higher Borg 0-10 ratings of dyspnoea and fatigue (both p < 0.001) compared to patients without persistent dyspnoea. We have shown that dyspnoea is a common persistent symptom across varying degrees of initial COVID-19 severity. Patients with persistent dyspnoea had greater restriction on spirometry, lower DLCO, reduced functional capacity, and increased exertional desaturation and symptoms. This suggests that there is a true physiological mechanism that may explain persistent dyspnoea after COVID-19.

Keywords: 6-Minute walk test; Breathlessness; Persistent symptoms; SARS-CoV-2.

Copyright © 2021 Elsevier B.V. All rights reserved.

References

    1. Carfi A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–605.
    1. Enright P.L., Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998;158:1384–1387.
    1. Faisal A., Alghamdi B.J., Ciavaglia C.E., Elbehairy A.F., Webb K.A., Ora J., Neder J.A., O’Donnell D.E. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am. J. Respir. Crit. Care Med. 2016;193:299–309.
    1. Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., Corre F., Zarrouk V., Moyer J.D., Galy A., Honsel V., Fantin B., Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81 e4-e6.
    1. Giannouchos T.V., Sussman R.A., Mier J.M., Poulas K., Farsalinos K. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases. Eur. Respir. J. 2020 Online Ahead of Print.
    1. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. Population. Am. J. Respir. Crit. Care Med. 1999;159:179–187.
    1. Holland A.E., Spruit M.A., Troosters T., Puhan M.A., Pepin V., Saey D., McCormack M.C., Carlin B.W., Sciurba F.C., Pitta F., Wanger J., MacIntyre N., Kaminsky D.A., Culver B.H., Revill S.M., Hernandes N.A., Andrianopoulos V., Camillo C.A., Mitchell K.E., Lee A.L., Hill C.J., Singh S.J. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 2014;44:1428–1446.
    1. Laviolette L., Laveneziana P., ERS Research Seminar Faculty Dyspnoea: a multidimensional and multidisciplinary approach. Eur. Respir. J. 2014;43:1750–1762.
    1. MacIntyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P., Brusasco V., Burgos F., Casaburi R., Coates A., Enright P., Gustafsson P., Hankinson J., Jensen R., McKay R., Miller M.R., Navajas D., Pedersen O.F., Pellegrino R., Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005;26:720–735.
    1. Mackey K., Ayers C.K., Kondo K.K., Saha S., Advani S.M., Young S., Spencer H., Rusek M., Anderson J., Veazie S., Smith M., Kansagara D. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths : a systematic review. Ann. Intern. Med. 2020 doi: 10.7326/M20-6306. online ahead of print M20-6306.
    1. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C., MacIntyre N., McKay R., Navajas D., Pedersen O.F., Pellegrino R., Viegi G., Wanger J. Standardisation of spirometry. Eur. Respir. J. 2005;26:319–338.
    1. Moxham J., Jolley C. Breathlessness, fatigue and the respiratory muscles. Clin. Med. Lond. (Lond) 2009;9:448–452.
    1. Ogedegbe G., Ravenell J., Adhikari S., Butler M., Cook T., Francois F., Iturrate E., Jean-Louis G., Jones S.A., Onakomaiya D., Petrilli C.M., Pulgarin C., Regan S., Reynolds H., Seixas A., Volpicelli F.M., Horwitz L.I. Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City. JAMA Netw Open. 2020;3
    1. Parra-Rodriguez L., Gonzalez-Meljem J.M., Gomez-Dantes H., Gutierrez-Robledo L.M., Lopez-Ortega M., Garcia-Pena C., Medina-Campos R.H. The burden of disease in Mexican older adults: premature mortality challenging a limited-resource health system. J. Aging Health. 2020;32:543–553.
    1. Stanojevic S., Graham B.L., Cooper B.G., Thompson B.R., Carter K.W., Francis R.W., Hall G.L., on behalf of the Global Lung Function Initiative TLCO working group Official ERS technical standards: global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur. Respir. J. 2017;50
    1. Wong A.W., Shah A.S., Johnston J.C., Carlsten C., Ryerson C.J. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur. Respir. J. 2020;56

Source: PubMed

3
Subskrybuj